Prevalence of Malnutrition and Frailty Among the Urban Community Elderly in Bandung

November 19, 2024 updated by: Istingadah Desiana, dr., SpKFR, Ger(K), FIPM(USG), Universitas Padjadjaran

The goal of this observational study is to learn prevalence of malnutrition and frailty in elderly in Community in Bandung. The main question it aims to answer:

what is the prevalence of malnutrition and frailty in elderly in Bandung community?

Study Overview

Status

Completed

Conditions

Detailed Description

The increase in the number and proportion of the elderly population poses various challenges, especially in the health sector. The elderly tend to be more vulnerable to health problems, such as malnutrition and frailty. Data on the prevalence of malnutrition and frailty in the elderly can be used as a basis for taking preventive and treatment measures for both conditions. This study aims to determine the prevalence of malnutrition and frailty in the elderly in the Bandung City community.

Descriptive research with a cross-sectional approach was conducted on 71 elderly participants in the Bandung City community. The sampling method used was consecutive sampling. The study used the Mini Nutritional Assessment-Short Form (MNA-SF) questionnaire to assess malnutrition and the Kihon Checklist (KCL) to assess frailty.

Study Type

Observational

Enrollment (Actual)

71

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • West Java
      • Bandung, West Java, Indonesia, 40261
        • Community Health Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The subject were taken form in each district there were a community health center that has an program integrated program specialized for elderly in each subdistrict. We took the subject samples from elderly that regularly visit this subdistrict program.

Description

Inclusion Criteria:

  • age above 60 years old
  • domicile in Bandung City
  • able to mobilize without assistive devices
  • able to see and read
  • willing to participate in the study

Exclusion Criteria:

  • history of hospitalization within the previous month
  • Mini Mental Status Examination ( MMSE ) score < 24

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Elderly living in community
The inclusion criteria were domicile in Bandung City, able to mobilize without assistive devices, able to see and read and willing to participate in the study after informed consent.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frailty
Time Frame: On enrollment
Frailty is a condition of reduced ability to cope with stressors due to increased vulnerability caused by age-related physiological decline. Frailty score in this study will be measured using Kihon Checklist (KCL) questionnaire that has 24 questions divided into seven categories that are physical strength, nutrition, eating problems, socialization, memory, mood, and lifestyle. The result will bed categorized into not frail (0-3 points), pre-frailty (4-7 points) and frailty (> 8 points).
On enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2022

Primary Completion (Actual)

November 30, 2022

Study Completion (Actual)

March 31, 2023

Study Registration Dates

First Submitted

November 13, 2024

First Submitted That Met QC Criteria

November 19, 2024

First Posted (Estimated)

November 22, 2024

Study Record Updates

Last Update Posted (Estimated)

November 22, 2024

Last Update Submitted That Met QC Criteria

November 19, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • IKFR-202411.01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Small sample size

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frail Elderly

3
Subscribe